Parabilis Medicines, Inc. (PBLS)
38.53
-0.83
(-2.11%)
USD |
NASDAQ |
Aug 24, 16:00
38.53
0.00 (0.00%)
After-Hours: 20:00
Parabilis Medicines Market Cap : 4.759B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 4.862B |
| August 20, 2026 | 4.889B |
| August 19, 2026 | 5.104B |
| August 18, 2026 | 4.861B |
| August 17, 2026 | 4.597B |
| August 14, 2026 | 4.579B |
| August 13, 2026 | 4.406B |
| August 12, 2026 | 4.621B |
| August 11, 2026 | 4.505B |
| August 10, 2026 | 4.221B |
| August 07, 2026 | 4.133B |
| August 06, 2026 | 4.204B |
| August 05, 2026 | 4.123B |
| August 04, 2026 | 4.241B |
| August 03, 2026 | 4.012B |
| July 31, 2026 | 4.015B |
| July 30, 2026 | 3.814B |
| July 29, 2026 | 3.755B |
| July 28, 2026 | 3.776B |
| Date | Value |
|---|---|
| July 27, 2026 | 3.759B |
| July 24, 2026 | 3.696B |
| July 23, 2026 | 3.876B |
| July 22, 2026 | 3.640B |
| July 21, 2026 | 3.549B |
| July 20, 2026 | 3.227B |
| July 17, 2026 | 3.491B |
| July 16, 2026 | 3.433B |
| July 15, 2026 | 3.534B |
| July 14, 2026 | 3.680B |
| July 13, 2026 | 3.501B |
| July 10, 2026 | 3.612B |
| July 09, 2026 | 3.587B |
| July 08, 2026 | 3.642B |
| July 07, 2026 | 3.586B |
| July 06, 2026 | 3.450B |
| July 02, 2026 | 3.495B |
| July 01, 2026 | 3.280B |
| June 30, 2026 | 3.234B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 55.39B |
| Kailera Therapeutics, Inc. | 2.144B |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
Market Cap Related Metrics
| PS Ratio | 31457.36 |
| Price to Book Value | 4.542 |
| Price | 38.53 |
| Earnings Yield | -4.97% |